Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Neurocritical Care|May 20, 2025
Systolic Blood Pressure Reduction with Stability as a New Therapeutic Goal in Patients with Intracerebral Hemorrhage: Results of the Pooled Analysis of ATACH 2 and INTERACT 2 TrialsAdnan I Qureshi, William Baskett, Renee H Martin, et al.
Annals of Neurology|November 14, 2018
Clinical Outcomes Depending on Acute Blood Pressure After Cerebral HemorrhageKazunori Toyoda, Masatoshi Koga, Haruko Yamamoto, et al.
Therapeutic Advances in Neurological Disorders|December 25, 2025
Safety and efficacy of oral anticoagulation in patients with intracranial hemorrhage and atrial fibrillation: a systematic review and meta-analysis of randomized controlled clinical trialsNikolaos M Papageorgiou, Lina Palaiodimou, Aikaterini Theodorou, et al.
Thrombosis and Haemostasis|May 29, 2015
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatranCharles V Pollack, Paul A Reilly, Richard Bernstein, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 24, 2024
Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOACBernhard M Siepen, Alexandros Polymeris, Ashkan Shoamanesh, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 7, 2015
The European Stroke Organisation Guidelines: a standard operating procedureGeorge Ntaios, Natan M Bornstein, Valeria Caso, et al.
Stroke|December 15, 2023
Code ICH: A Call to ActionQi Li, Aleksandra Yakhkind, Anne W Alexandrov, et al.
European Stroke Journal|June 13, 2024
CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysisAikaterini Theodorou, Ioanna Tsantzali, Maria-Ioanna Stefanou, et al.
The Lancet. Neurology|November 22, 2024
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trialKevin N Sheth, Gregory W Albers, Jeffrey L Saver, et al.
The New England Journal of Medicine|June 23, 2015
Idarucizumab for Dabigatran ReversalCharles V Pollack, Paul A Reilly, John Eikelboom, et al.
Pageof 17